[MOL] Some excelent articles to help our Moler Friends.... [01755] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Some excelent articles to help our Moler Friends....



JOURNAL SCAN - HEMATOLOGY-ONCOLOGY 3(7)
Analysis and evaluation of the recent oncology literature by Harold J.
Burstein, MD, of Dana-Farber Cancer Institute.
http://oncology.medscape.com/25038.rhtml
<a href="http://oncology.medscape.com/25038.rhtml">Read it Here</a>

HEREDITARY NONPOLYPOSIS COLORECTAL CANCER: SCREENING CAN IMPACT CANCER
MORTALITY
Can screening for hereditary nonpolyposis colorectal cancer impact mortality?
Copyright (C) 1998, 1999, 2000 The McGraw-Hill Companies.
http://oncology.medscape.com/25047.rhtml
<a href="http://oncology.medscape.com/25047.rhtml">Read it Here</a>

ASK THE EXPERTS - SIGNIFICANCE OF POSITIVE PERITONEAL WASHINGS IN
ENDOMETRIAL CANCER?
A 60-year-old woman had a staging laparotomy with TAH+BSO because of
endometrial carcinoma G2.
http://oncology.medscape.com/25059.rhtml
<a href="http://oncology.medscape.com/25059.rhtml">Read it Here</a>

ASK THE EXPERTS - SURGERY AFTER DOWNSTAGING OF N1/N2 LUNG CANCER?
The patient is a 68-year-old man with a technically resectable lung mass
but with multiple hilar lymphadenopathy.
http://oncology.medscape.com/25095.rhtml
<a href="http://oncology.medscape.com/25095.rhtml">Read it Here</a>
_______________________________________________________________________
___________________________________ NEWS ______________________________

STUDY LINKS ENVIRONMENTAL CONTAMINANTS WITH BREAST CANCER
Researchers from Columbia Presbyterian Medical Center in New York, have
found an association between exposure to common environmental contaminants
and breast cancer.
http://oncology.medscape.com/25065.rhtml
<a href="http://oncology.medscape.com/25065.rhtml">Read it Here</a>

NADER BLASTS GORE'S RECORD ON CHILD ENVIRONMENTAL HEALTH
The Clinton/Gore administration has not made good on its promises to
protect American children from exposure to harmful toxins in their
environment, Green Party presidential candidate Ralph Nader said today at
a
forum on children's environmental health.
http://oncology.medscape.com/24908.rhtml
<a href="http://oncology.medscape.com/24908.rhtml">Read it Here</a>

LOW-DOSE OCS AS PROTECTIVE AGAINST OVARIAN CANCER AS OLDER, HIGH-DOSE PILLS
Low-dose contraceptives currently on the market are just as effective as
the older, high-dose preparations in protecting women from ovarian cancer,
according to investigators from the University of Pittsburgh Graduate
School of Public Health (GSPH) in a paper published in the August 1 issue
of the American Journal of Epidemiology.
http://oncology.medscape.com/25071.rhtml
<a href="http://oncology.medscape.com/25071.rhtml">Read it Here</a>

ANTICONVULSANT THERAPY REDUCES THE EFFECTIVENESS OF ALL CHEMOTHERAPY
Long-term treatment with anticonvulsants increases the systemic clearance
of several antileukemic drugs and can reduce the effectiveness of
chemotherapy for acute lymphoblastic leukemia, according to a report in
the
July 22nd issue of The Lancet.
http://oncology.medscape.com/24839.rhtml
<a href="http://oncology.medscape.com/24839.rhtml">Read it Here</a>

ELECTIVE LIVER RESECTION ASSOCIATED WITH LOW RISK OF MORTALITY
With the basic risk of mortality from elective liver resection at about
1%,
French researchers believe that indications for resection for malignancy
could be extended.
http://oncology.medscape.com/24846.rhtml
<a href="http://oncology.medscape.com/24846.rhtml">Read it Here</a>

UK NONPROFIT WARNS OF DANGER OF BETA-CAROTENE TO SMOKERS
A leading British cancer charity on Friday called for health warnings on
vitamin supplements containing beta-carotene, saying that such supplements
can increase a smoker's risk of developing lung cancer.
http://oncology.medscape.com/24864.rhtml
<a href="http://oncology.medscape.com/24864.rhtml">Read it Here</a>

'VIRTUAL MICROSCOPE' SHOULD SPEED DIAGNOSIS OF CANCER, OTHER DISEASES
Computer experts are developing a 'virtual microscope' that should make
it
easier for physicians to diagnose cancer and other diseases, by examining
digitized data samples instead of traditional slides.
http://oncology.medscape.com/24956.rhtml
<a href="http://oncology.medscape.com/24956.rhtml">Read it Here</a>

PET BETTER THAN CT AT STAGING LUNG CANCER, DETECTING METASTASIS
Compared with computed tomography, whole-body positron-emission tomography
(PET) provides more accurate staging and detects local and distant
metastases better than in patients with resectable non-small-cell lung
cancer, according to researchers in the Netherlands.
http://oncology.medscape.com/25004.rhtml
<a href="http://oncology.medscape.com/25004.rhtml">Read it Here</a>

MORE OLDER AMERICAN WOMEN UNDERGOING MAMMOGRAPHY
Most American women ages 50 and older report have had a mammogram in the
past 2 years, according to a report released yesterday by the Centers for
Disease Control and Prevention's National Center for Health Statistics.
http://oncology.medscape.com/25006.rhtml
<a href="http://oncology.medscape.com/25006.rhtml">Read it Here</a>

NEW DIAGNOSTIC TECHNIQUE FOR STEREOTACTIC BREAST BIOPSY OFFERS EXCISION
BENEFIT
Advanced Breast Biopsy Instrumentation (ABBI) exhibited 100% specificity
and sensitivity in a case series of 150 consecutive patients with
nonpalpable mammographic lesions.
http://oncology.medscape.com/24895.rhtml
<a href="http://oncology.medscape.com/24895.rhtml">Read it Here</a>

LASER TREATMENT ALLOWS KILLING OF BREAST CANCERS IN SITU
A new laser treatment developed by researchers at Rush-Presbyterian-St.
Luke's Medical Center kills breast cancer cells in situ and could someday
replace lumpectomy in women with small breast cancers detected by
mammography.
http://oncology.medscape.com/25136.rhtml
<a href="http://oncology.medscape.com/25136.rhtml">Read it Here</a>

MORE EXTENSIVE BIOPSY PROTOCOL IMPROVES PROSTATE CANCER DETECTION RATE
Adding peripheral cores to the six standard sextant needle biopsies of the
prostate significantly improves the cancer detection rate, French
researchers report in the August issue of the Journal of Urology.
http://oncology.medscape.com/25128.rhtml
<a href="http://oncology.medscape.com/25128.rhtml">Read it Here</a>

COMPUTERIZED TOOL DETECTS EARLY PROSTATE CANCER
A computerized diagnostic index for detecting prostate cancer in patients
with prostate-specific antigen levels ranging from 2.5 to 4.0 will be
presented Thursday at the 52nd annual meeting of the American Association
for Clinical Chemistry, in San Francisco, California.
http://oncology.medscape.com/24943.rhtml
<a href="http://oncology.medscape.com/24943.rhtml">Read it Here</a>

SEVERAL FACTORS PREDICT RISK OF PROGRESSION OF BARRETT'S ESOPHAGUS TO CANCER
Aneuploidy, increased 4N fractions, or high-grade dysplasia identified by
endoscopic biopsy suggest that a patient with Barrett's esophagus is at
high risk of progression to cancer.
http://oncology.medscape.com/25129.rhtml
<a href="http://oncology.medscape.com/25129.rhtml">Read it Here</a>

TRIPLE REGIMEN PROMISING FOR NON-HODGKIN'S LYMPHOMA, LYMPHOCYTIC LEUKEMIA
The combination of fludarabine, cyclophosphamide and filgrastim is a highly
active, well-tolerated regimen for patients with low-grade lymphoid
malignancies, researchers report in the July 1st issue of Blood.
http://oncology.medscape.com/24881.rhtml
<a href="http://oncology.medscape.com/24881.rhtml">Read it Here</a>

ENDOSTATIN PLUS CHEMOTHERAPY TREATS NON-HODGKIN'S LYMPHOMA IN MICE
Sequential administration of chemotherapy and the antiangiogenic drug
endostatin prevents tumor growth in a mouse model of human non-Hodgkin's
lymphoma, and the regimen may hold promise for treating NHL in patients,
Italian researchers report in the July 1st issue of Blood.
http://oncology.medscape.com/24915.rhtml
<a href="http://oncology.medscape.com/24915.rhtml">Read it Here</a>

BEXXAR ENTERS PHASE II TRIAL FOR INTERMEDIATE-STAGE NON-HODGKIN'S LYMPHOMA
Coulter Pharmaceutical and SmithKline Beecham have begun an open-label,
multicenter phase II trial of Bexxar (tositumomab, iodine I 131
tositumomab) in combination with cyclophosphamide, doxorubicin, vincristine
and prednisone (CHOP) chemotherapy as a first-line treatment for
intermediate-grade non-Hodgkin's lymphoma (NHL), the companies announced
on
Wednesday.
http://oncology.medscape.com/25012.rhtml
<a href="http://oncology.medscape.com/25012.rhtml">Read it Here</a>

FILGRASTIM SPEEDS NEUTROPHIL RECOVERY AFTER STEM CELL TRANSPLANTATION
Treatment with filgrastim after allogeneic blood stem cell transplantation
improves the recovery rate of neutrophils.
http://oncology.medscape.com/25127.rhtml
<a href="http://oncology.medscape.com/25127.rhtml">Read it Here</a>

ASTHMA DRUG HAS ANTI-SICKLE CELL EFFECTS
A single dose of low-dose cromolyn sodium causes a 'striking decrease' in
sickle cells in African children with severe sickle-cell disease.
http://oncology.medscape.com/24840.rhtml
<a href="http://oncology.medscape.com/24840.rhtml">Read it Here</a>

GENTA'S GENE DRUG ENHANCES CHEMOTHERAPY FOR BREAST CANCER
Genasense, an investigational drug made by Genta Incorporated, has shown
promise as a chemotherapy enhancer as a treatment or breast cancer when
used in combination with doxorubicin, according to results of a preclinical
study.
http://oncology.medscape.com/24963.rhtml
<a href="http://oncology.medscape.com/24963.rhtml">Read it Here</a>

LOW P27 LEVELS ASSOCIATED WITH UNFAVORABLE PROGNOSIS OF RENAL/PELVIC CANCER
Low levels of the cyclin-dependent kinase inhibitor p27-Kip1 (p27) or a
high Ki-67 index are associated with an unfavorable prognosis in patients
with transitional cell carcinoma of the renal pelvis and ureter, Japanese
researchers report in the July issue of the British Journal of Urology
International.
http://oncology.medscape.com/24976.rhtml
<a href="http://oncology.medscape.com/24976.rhtml">Read it Here</a>

ANDROGEN RECEPTOR GENE VARIATION PREDICTS PROSTATE CANCER RECURRENCE IN
LOW-RISK MEN
The risk of prostate cancer recurrence among patients otherwise considered
to be at low-risk for recurrence is increased for those with 18 or fewer
CAG repeats in the androgen receptor gene, Canadian researchers report.
http://oncology.medscape.com/25003.rhtml
<a href="http://oncology.medscape.com/25003.rhtml">Read it Here</a>

GEL DOSIMETRY WILL ALLOW MORE ACCURATE IMAGING, RADIATION THERAPY
Scientists are making progress with gel dosimetry, but they are not ready
to take the technique into the clinical setting, according to researchers
who spoke here Monday during a mini-symposium at the World Congress on
Medical Physics and Biomedical Engineering.
http://oncology.medscape.com/25011.rhtml
<a href="http://oncology.medscape.com/25011.rhtml">Read it Here</a>

CME PROGRAM HELPS MEET EDUCATIONAL NEEDS OF BRITISH MDS
An online continuing medical education (CME) program, Melanoma Education
for Primary Care, has received approval from the Post Graduate Education
Authority (PGEA) of the Royal College of General Practitioners in London
to
offer 18 hours of approved credit in disease management and health
promotion.
http://oncology.medscape.com/25062.rhtml
<a href="http://oncology.medscape.com/25062.rhtml">Read it Here</a>
 
 
We invite you to take a look at our Album.                                               
www.angelfire.com/sc/molangels/index.html
 
  ( Very informational, good tips, Molers pictures, art work and much more....